Hyperglycemia in pregnancy and developmental outcomes in children at 18-60 months of age: the PANDORA Wave 1 study.


Journal

Journal of developmental origins of health and disease
ISSN: 2040-1752
Titre abrégé: J Dev Orig Health Dis
Pays: England
ID NLM: 101517692

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 5 4 2022
medline: 10 11 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

This study aimed to explore the association between hyperglycemia in pregnancy (type 2 diabetes (T2D) and gestational diabetes mellitus (GDM)) and child developmental risk in Europid and Aboriginal women.PANDORA is a longitudinal birth cohort recruited from a hyperglycemia in pregnancy register, and from normoglycemic women in antenatal clinics. The Wave 1 substudy included 308 children who completed developmental and behavioral screening between age 18 and 60 months. Developmental risk was assessed using the Ages and Stages Questionnaire (ASQ) or equivalent modified ASQ for use with Aboriginal children. Emotional and behavioral risk was assessed using the Strengths and Difficulties Questionnaire. Multivariable logistic regression was used to assess the association between developmental scores and explanatory variables, including maternal T2D in pregnancy or GDM.After adjustment for ethnicity, maternal and child variables, and socioeconomic measures, maternal hyperglycemia was associated with increased developmental "concern" (defined as score ≥1 SD below mean) in the fine motor (T2D odds ratio (OR) 5.30, 95% CI 1.77-15.80; GDM OR 3.96, 95% CI 1.55-10.11) and problem-solving (T2D OR 2.71, 95% CI 1.05-6.98; GDM OR 2.54, 95% CI 1.17-5.54) domains, as well as increased "risk" (score ≥2 SD below mean) in at least one domain (T2D OR 5.33, 95% CI 1.85-15.39; GDM OR 4.86, 95% CI 1.95-12.10). Higher maternal education was associated with reduced concern in the problem-solving domain (OR 0.27, 95% CI 0.11-0.69) after adjustment for maternal hyperglycemia.Maternal hyperglycemia is associated with increased developmental concern and may be a potential target for intervention so as to optimize developmental trajectories.

Identifiants

pubmed: 35373733
pii: S2040174422000101
doi: 10.1017/S2040174422000101
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

695-705

Auteurs

Angela Titmuss (A)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Paediatric Department, Division of Women, Children and Youth, Royal Darwin Hospital, Darwin, NT, Australia.

Anita D'Aprano (A)

Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Centre for Child Development and Education, Menzies School for Health Research, Charles Darwin University, Darwin, NT, Australia.

Federica Barzi (F)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Poche Centre for Indigenous Health, University of Queensland, Brisbane, QLD, Australia.

Alex D H Brown (ADH)

Wardliparingga Aboriginal Research Unit, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
University of South Australia, Adelaide, SA, Australia.

Anna Wood (A)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Endocrinology Department, Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.

Christine Connors (C)

Northern Territory Department of Health, Darwin, NT, Australia.

Jacqueline A Boyle (JA)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Elizabeth Moore (E)

Public Health Unit, Aboriginal Medical Services Alliance of Northern Territory, Darwin, NT, Australia.

Kerin OʼDea (K)

University of South Australia, Adelaide, SA, Australia.

Jeremy Oats (J)

Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.

H David McIntyre (HD)

Faculty of Medicine, Mater Medical Research Institute, University of Queensland, Brisbane, QLD, Australia.

Paul Zimmet (P)

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

Jonathan E Shaw (JE)

Clinical and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Maria E Craig (ME)

School of Women and Children's Health, University of New South Wales, Sydney, NSW, Australia.

Louise J Maple-Brown (LJ)

Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Endocrinology Department, Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH